Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens. [electronic resource] by
- Yildiz, Ramazan
- Kalender, Mehmet Emin
- Dane, Faysal
- Sevinc, Alper
- Gumus, Mahmut
- Camci, Celalettin
- Alici, Suleyman
- Kaya, Ali Osman
- Yaman, Emel
- Ozturk, Banu
- Coskun, Ugur
- Benekli, Mustafa
- Uncu, Dogan
- Buyukberber, Suleyman
Producer: 20101210
In:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners vol. 16
Availability: No items available.
|
|
|
6.
|
A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancer. [electronic resource] by
- Wisinski, Kari B
- Ledesma, Wendy M
- Kolesar, Jill
- Wilding, George
- Liu, Glenn
- Douglas, Jeffrey
- Traynor, Anne M
- Albertini, Mark
- Mulkerin, Daniel
- Bailey, Howard H
Producer: 20160816
In:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners vol. 21
Availability: No items available.
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
|
|
|
19.
|
|
|
|
20.
|
|